← All trials
NCT04639674
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 2, 2020
- Primary completion
- Jun 30, 2021
- Completion date
- Dec 31, 2021
- First posted
- Nov 20, 2020
- Last posted
- Nov 20, 2020
- Enrollment
- 150
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- ConMed CorporationLead sponsor
- Tung's Taiching MetroHarbor HospitalCollaborator
- Chang Gung UniversityStudy chair
- Chang Gung UniversityCollaborator
- Tzu Chi UniversityCollaborator
- Government of TaiwanStudy chair
- Government of TaiwanCollaborator
- Taichung Veterans General HospitalStudy chair
- Taichung Veterans General HospitalCollaborator
- Kaohsiung Medical UniversityStudy chair
- Kaohsiung Medical UniversityCollaborator
- Taipei Buddhist Tzu Chi Medical FoundationOverall official - principal investigator
- Tung's Taiching MetroHarbor HospitalStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.